Latest news with #AureliaMetals
Business Insider
3 days ago
- Business
- Business Insider
Ord Minnett Keeps Their Buy Rating on Aurelia Metals (AUMTF)
Ord Minnett analyst Paul Kaner maintained a Buy rating on Aurelia Metals (AUMTF – Research Report) today and set a price target of A$0.31. The company's shares closed last Wednesday at $0.13. Don't Miss TipRanks' Half Year Sale Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Kaner is a 5-star analyst with an average return of 24.0% and a 63.58% success rate. Kaner covers the Basic Materials sector, focusing on stocks such as Aurelia Metals , Ramelius Resources Limited, and Red 5 Limited. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Aurelia Metals with a $0.21 average price target, representing a 58.25% upside. In a report released on June 27, Macquarie also maintained a Buy rating on the stock with a A$0.27 price target. The company has a one-year high of $0.22 and a one-year low of $0.05. Currently, Aurelia Metals has an average volume of 3,450.
Business Insider
3 days ago
- Business
- Business Insider
Aurelia Metals (AUMTF) Receives a Buy from Macquarie
Macquarie analyst Adam Baker maintained a Buy rating on Aurelia Metals (AUMTF – Research Report) on June 27 and set a price target of A$0.27. The company's shares closed last Wednesday at $0.13. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Baker covers the Basic Materials sector, focusing on stocks such as Aurelia Metals , Sandfire Resources Limited, and FireFly Metals. According to TipRanks, Baker has an average return of -16.4% and a 45.24% success rate on recommended stocks. Aurelia Metals has an analyst consensus of Strong Buy, with a price target consensus of $0.20, a 50.72% upside from current levels. In a report released on June 25, Jefferies also maintained a Buy rating on the stock with a A$0.28 price target.
Business Insider
25-06-2025
- Business
- Business Insider
MA Financial Group Sticks to Their Buy Rating for Aurelia Metals (AUMTF)
MA Financial Group analyst Paul Hissey maintained a Buy rating on Aurelia Metals (AUMTF – Research Report) on June 23 and set a price target of A$0.31. The company's shares closed last Monday at $0.13. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Hissey is a 4-star analyst with an average return of 19.5% and a 53.66% success rate. Hissey covers the Basic Materials sector, focusing on stocks such as Gold Road Resources Ltd, Hillgrove Resources Limited, and Alkane Resources Ltd. Currently, the analyst consensus on Aurelia Metals is a Strong Buy with an average price target of $0.22, a 66.67% upside from current levels. In a report released on June 20, Macquarie also maintained a Buy rating on the stock with a A$0.25 price target.
Business Insider
19-06-2025
- Business
- Business Insider
MA Financial Group Remains a Buy on Aurelia Metals (AUMTF)
In a report released today, Paul Hissey from MA Financial Group maintained a Buy rating on Aurelia Metals (AUMTF – Research Report), with a price target of A$0.40. The company's shares closed last Thursday at $0.22. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Hissey is a 5-star analyst with an average return of 23.4% and a 60.00% success rate. Hissey covers the Basic Materials sector, focusing on stocks such as Gold Road Resources Ltd, Hillgrove Resources Limited, and Alkane Resources Ltd. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Aurelia Metals with a $0.23 average price target.
Yahoo
18-06-2025
- Business
- Yahoo
ASX Growth Stocks With High Insider Ownership To Watch
As the Australian market remains relatively flat, with the ASX hovering close to 8,542 points and sectors like IT outperforming while Materials face pressure, investors are closely watching potential tax reforms that could impact future economic conditions. In this environment, growth companies with high insider ownership can be particularly appealing as they often signal strong internal confidence and alignment of interests between management and shareholders. Name Insider Ownership Earnings Growth Titomic (ASX:TTT) 11.2% 77.2% Newfield Resources (ASX:NWF) 31.5% 72.1% Image Resources (ASX:IMA) 20.6% 79.9% Fenix Resources (ASX:FEX) 21.1% 53.4% Echo IQ (ASX:EIQ) 18% 65.9% Cyclopharm (ASX:CYC) 11.3% 97.8% Brightstar Resources (ASX:BTR) 11.6% 106.7% Alfabs Australia (ASX:AAL) 10.8% 41.3% Adveritas (ASX:AV1) 21% 88.8% Acrux (ASX:ACR) 15.5% 106.9% Click here to see the full list of 94 stocks from our Fast Growing ASX Companies With High Insider Ownership screener. Let's review some notable picks from our screened stocks. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Aurelia Metals Limited is involved in the exploration and production of mineral properties in Australia, with a market cap of A$516.23 million. Operations: The company's revenue is derived from its operations at the Hera Mine (A$5.98 million), Peak Mine (A$245.13 million), and Dargues Mine (A$73.90 million). Insider Ownership: 23.9% Revenue Growth Forecast: 14.6% p.a. Aurelia Metals is poised for significant growth, with earnings expected to rise 45.29% annually, outpacing the Australian market's 11.6%. Revenue growth is projected at 14.6% per year, surpassing the market average of 5.6%. The stock trades at a substantial discount to its estimated fair value, suggesting potential upside. Recent events include an Analyst/Investor Day focusing on strategic growth opportunities and a change in registered office location to Brisbane, enhancing operational efficiency. Click to explore a detailed breakdown of our findings in Aurelia Metals' earnings growth report. Our valuation report unveils the possibility Aurelia Metals' shares may be trading at a premium. Simply Wall St Growth Rating: ★★★★★☆ Overview: PWR Holdings Limited specializes in the design, prototyping, production, testing, validation, and sale of cooling products and solutions across various international markets with a market cap of A$661.71 million. Operations: PWR Holdings Limited generates revenue from two main segments: PWR C&R, contributing A$46.48 million, and PWR Performance Products, contributing A$109.04 million. Insider Ownership: 13.3% Revenue Growth Forecast: 13.4% p.a. PWR Holdings is positioned for robust growth, with earnings anticipated to increase by 24.56% annually, exceeding the Australian market's average of 11.6%. Analysts agree on a potential stock price rise of 25.6%, while it currently trades at a discount to its fair value estimate. Insider confidence is evident with substantial share purchases and no significant sales over the past three months, reinforcing positive sentiment around its future performance. Take a closer look at PWR Holdings' potential here in our earnings growth report. The analysis detailed in our PWR Holdings valuation report hints at an deflated share price compared to its estimated value. Simply Wall St Growth Rating: ★★★★★☆ Overview: Telix Pharmaceuticals Limited is a commercial-stage biopharmaceutical company that develops and commercializes therapeutic and diagnostic radiopharmaceuticals for cancer and rare diseases across Australia, Belgium, Japan, Switzerland, and the United States, with a market cap of A$8.71 billion. Operations: The company's revenue is primarily derived from three segments: Therapeutics (A$9.35 million), Precision Medicine (A$771.11 million), and Manufacturing Solutions (A$2.75 million). Insider Ownership: 14.9% Revenue Growth Forecast: 19.8% p.a. Telix Pharmaceuticals is experiencing significant growth, with earnings expected to increase by 32.8% annually, outpacing the Australian market average. The company trades at a considerable discount to its fair value estimate and shows no substantial insider selling recently, indicating confidence in its prospects. Recent approvals of Telix's prostate cancer imaging agents across Europe and the U.S., including Illuccix® and Gozellix®, enhance its market presence and support future revenue expansion. Click here and access our complete growth analysis report to understand the dynamics of Telix Pharmaceuticals. Insights from our recent valuation report point to the potential undervaluation of Telix Pharmaceuticals shares in the market. Investigate our full lineup of 94 Fast Growing ASX Companies With High Insider Ownership right here. Contemplating Other Strategies? Uncover 16 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include ASX:AMI ASX:PWH and ASX:TLX. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data
